Skip to main content
SpringerLink
Log in

Extending the endocrine hypertension spectrum: novel nonclassic apparent mineralocorticoid excess

  • Letter to the Editor
  • Published:
Endocrine Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. L. Mosso, C. Carvajal, A. Gonzalez, A. Barraza, F. Avila, J. Montero, A. Huete, A. Gederlini, C.E. Fardella, Primary aldosteronism and hypertensive disease. Hypertension 42, 161–165 (2003)

    Article  CAS  Google Scholar 

  2. R. Baudrand, F.J. Guarda, C. Fardella, G. Hundemer, J. Brown, G. Williams, A. Vaidya, Continuum of renin-independent aldosteronism in normotension. Hypertension 69, 950–956 (2017)

    Article  CAS  Google Scholar 

  3. A. Tapia-Castillo, R. Baudrand, A. Vaidya, C. Campino, F. Allende, C. Valdivia, A. Vecchiola, C.F. Lagos, C.A. Fuentes, S. Solari, A. Martinez-Aguayo, H. Garcia, C.A. Carvajal, C.E. Fardella, Clinical, biochemical, and genetic characteristics of “nonclassic” apparent mineralocorticoid excess syndrome. J. Clin. Endocrinol. Metab. 104, 595–603 (2019)

    Article  Google Scholar 

  4. C.A. Carvajal, A. Tapia-Castillo, A. Vecchiola, R. Baudrand, C.E. Fardella, Classic and nonclassic apparent mineralocorticoid excess syndrome. J. Clin. Endocrinol. Metab. 105, e924–e936 (2020).

Download references

Funding

This study was supported partially by the Grants: ANID/CONICYT-FONDECYT 1160695, 1190250, 1212006; FONDECYT POSTDOCTORAL 3200646; CONICYT-FONDEQUIP EQM150023; ANID – Millennium Science Initiative Program- IMII P09/016-F, ICN09_016; CORFO BMRC-13CTI-21526-P1; SOCHED 2019-09 and CETREN-UC.

Author information

Authors and Affiliations

  1. Department of Endocrinology, School of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile

    Cristian A. Carvajal, Alejandra Tapia-Castillo & Carlos E. Fardella

  2. Millennium Institute on Immunology and Immunotherapy (IMII-ICM), Santiago, Chile

    Cristian A. Carvajal, Alejandra Tapia-Castillo & Carlos E. Fardella

  3. Centro Traslacional de Endocrinología UC (CETREN-UC), Santiago, Chile

    Cristian A. Carvajal, Alejandra Tapia-Castillo & Carlos E. Fardella

Authors
  1. Cristian A. Carvajal
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Alejandra Tapia-Castillo
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Carlos E. Fardella
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Cristian A. Carvajal or Carlos E. Fardella.

Ethics declarations

Conflict of interest

The authors declare no competing interests.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Carvajal, C.A., Tapia-Castillo, A. & Fardella, C.E. Extending the endocrine hypertension spectrum: novel nonclassic apparent mineralocorticoid excess. Endocrine 74, 437–439 (2021). https://doi.org/10.1007/s12020-021-02783-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12020-021-02783-1

Search

Navigation